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Abstract
Background Enhanced Recovery After Surgery (ERAS) programs are associated with reduced hospital morbidity and
mortality. The aim of the present study was to evaluate whether the introduction of ERAS care improved the adverse events
in colorectal surgery. In a cohort study, mortality, morbidity, and length of stay were compared between ERAS patients and
carefully matched historical controls.
Methods Patients were matched for their type of disease, the type of surgery, P-Possum (Portsmouth-Possum), CR-Possum
(Colorectal-Possum) Physiological and Operative Score for Enumeration of Mortality and Morbidity (POSSUM), gender,
and American Society of Anesthesiologists (ASA) grade. The primary outcome measures of this study were mortality and
morbidity. Secondary outcome measures were fluid intake, length of hospital stay, the number of relaparotomies, and the
number of readmissions within 30 days. Data on the ERAS patients were collected prospectively.
Results Sixty-one patients treated according to the ERAS program were compared with 122 patients who received
conventional postoperative care. The two groups were comparable with respect to age, ASA grade, P-Possum (Portsmouth-
Possum), CR-Possum (Colorectal-Possum) score, type of surgery, stoma formation, type of disease, and gender. Morbidity
was lower in the ERAS group compared to the control group (14.8% versus 33.6% respectively; P=<0.01). Patients in the
ERAS group received significantly less fluid and spent fewer days in the hospital (median 6 days, range 3–50 vs. median
9 days, range 3–138; P=0.032). There was no difference between the ERAS and the control group for mortality (0% vs.
1.6%; P=0.55) and readmission rate (3.3% vs. 1.6%; P=0.60).
Conclusion Enhanced Recovery After Surgery program reduces morbidity and the length of hospital stay for patients
undergoing elective colonic or rectal surgery.
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Introduction
Colorectal resections are associated with an in-hospital stay
of 6 to 11 days and a complication rate of 15% to 20%.
“Fast-track” or enhanced recovery programs are developed
to improve perioperative care in these patients.
1–3
Enhanced Recovery After Surgery (ERAS) protocols aim
at reducing the surgical stress response and optimizing
recovery, thus reducing the length of hospital stay. All
elements in ERAS separately have been shown to improve
patient outcome. Preoperative education about the ERAS
program diminishes anxiety and is associated with an earlier
return of gastrointestinal motility after surgery.
4 Preoperative
carbohydrate loading is associated with earlier return of
gastrointestinal motility and a significantly shorter hospital
stay.
5 Colonic lavages are associated with patient discomfort
and electrolyte disturbances and can safely be avoided in
elective colonic surgery.
6–10 Epidural analgesia provides
better treatment of postoperative pain and leads to an earlier
gastrointestinal motility.
11,12 Hypotension, a common phys-
iologic side effect of epidural analgesia, can be treated safely
with a vasopressor.
13 Postoperative pain relief is best
managed without opioid analgesia because of the adverse
effects it has on the central nervous system, respiratory
function, and gastrointestinal function.
14
Intraoperative fluid management aiming at a zero balance
reduces the number of patients who experience morbidity and
shortens the time to the recovery of gastrointestinal motility and
reduces hospital stay.
15,16 Early postoperative enteral feeding
shows a reduction in the risk of postoperative complications,
hospital stay, and mortality.
17 Bed rest after surgery is
undesirable because it impairs pulmonary function and tissue
oxygenation and predisposes to pulmonary complications.
18
To avoid this, mobilizing patients as soon as possible is an
important factor in improving postoperative care.
The aim of the present study was to compare mortality,
morbidity, and in-hospital stay in a cohort of carefully
matched patients receiving conventional postoperative care
and the ERAS program to evaluate the clinical relevance of
the improved perioperative care.
Methods
Identification of Patients
A cohort of consecutive patients that underwent elective open
colonic or rectal resection following the ERAS regime was
compared with a matched historical cohort who underwent
colonic or rectal resection with conventional perioperative
care. Between May 2006 and July 2008, patients who were
above 18 years of age and were scheduled for any colonic or
rectal resection and had an American Society of Anesthesiol-
ogists (ASA) grade of 1–3w e r et r e a t e da c c o r d i n gt oa nE R A S
program. In all patients, a colorectal resection was performed,
with or without primary anastomosis. A loop ileostomy was
c r e a t e di na n yl o wr e c t a la n a s t omosis and in patients with a
high estimated risk to develop anastomotic leakage.
Running two protocols of postoperative care in one
surgical ward would be prone to bias in a randomized trial.
Forthis reason,a matchedcohortstudy was performed.Since
all eligible patients operated in the time span mentioned
above received ERAS, a historical control group was used,
composed of patients that would have been eligible for
ERAS in the successive period. Patients in the control group
were operated from January 2003 to May 2006. The latter
group was obtained from a surgical database. All procedures
were performed by the same team of surgeons.
Each patient from the ERAS group was matched with two
patients from the control group on age, gender, P-Possum
(Portsmouth-Possum), CR-Possum (Colorectal-Possum) Phy-
siological and Operative Score for Enumeration of Mortality
and Morbidity (POSSUM), American Society of Anesthesiol-
ogists grade, type of disease, and surgical procedure.
Criteria of Exclusion
Patients with an ASA grade 4–5 and younger than 18 years
were excluded from analysis.
ERAS Protocol
In the outpatient clinic, patients who were treated according
to the ERAS protocol were informed about the operative
procedure and rehabilitation program. Before surgery,
patients were consulted by an anesthesiologist and if
necessary by a dietitian. All patients were admitted the
day before surgery and could eat until midnight, including
four drinks of carbohydrate (PreOP®, Nutricia; Numico,
Zoetermeer, the Netherlands). Patients could drink water
freely until 2 h before surgery. Two hours before surgery,
patients received two drinks of PreOP®.
In the case of a planned left-sided resection, a phosphate
enema was given the evening before and on the day of
surgery. Thrombotic prophylaxis (nadroparin 2850 IE) was
started the day before surgery. Antibiotic prophylaxis
(cefazolin 2 g and metronidazole 500 mg intravenously)
was given 30 min before incision. A transverse incision was
preferred, except in Crohn’s disease and rectal surgery. In
order to maintain a normothermic body temperature, the
temperature in the operating theatre was increased to 22°C,
and a Bair hugger and warmed intravenous fluids were
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analgesia and general anesthesia. Before the induction of
anesthesia, an epidural catheter was inserted at level Th7/8.
After the confirmation of proper placement by a test dose
(Lignocaine 2% 3 ml), bolus infusion of 4 ml sufentanil
produced sufficient analgesia for the first 30 min of
surgery. Afterwards, repeated bolus infusion of 2–3m l
bupivacaine 0.5% maintained the operative analgesia. No
additional opioids were given intravenously. At the end of
surgery, continuous epidural infusion of 6 ml/h of ropiva-
cain 0.2% with 1 μg/ml sufentanil was started for post-
operative analgesia. This infusion lasted for 2 days
postoperatively.
During and after surgery, hypotension was preferably
treated with a vasopressor agent (ephedrine 5 mg or
phenylefrine 0,1 mg) instead of intravenous fluid bolus in
order to maintain a neutral fluid balance throughout the
perioperative period. No drains were used except in rectal
surgery, and the nasogastric tubes were removed immedi-
ately after surgery. To prevent postoperative nausea and
vomiting, 4 mg ondansetron was administered intravenous-
ly at the end of surgery. After surgery, the patient was
allowed to drink water, and, if tolerated, patients received
two drinks of PreOP®. On postoperative day 1, patients
were offered a normal diet. Intravenous fluid administration
aimed at a urine production of at least 0.5 ml/kg and the
total fluid intake should not exceed 2 l/24 h. Fluid balances
were recorded daily. A structured mobilization program was
also included in the ERAS protocol. Patients were
encouraged to sit out of bed on the day of surgery and to
walk the length of the ward on the first postoperative day.
The inserted urinary catheter was removed at the same time
as the thoracic epidural catheter. Subsequently, pain was
managed with paracetamol and nonsteroidal anti-
inflammatory drugs. The use of oral opioid analgesics was
limited to relieve breakthrough pain.
Each protocol item and any deviation from the
protocol was noted on a bedside checklist. Discharge
criteria were: adequate pain relief on non-opioid oral
analgesia, normal food intake, and return to preoperative
mobility level.
Conventional Postoperative Care Protocol
The perioperative care, before the ERAS program was
implemented, was according to the surgeon’s preference.
Thrombotic and antibiotic prophylaxis was given and the
practice of bowel preparation was largely abandoned.
Discharge criteria were identical to the ERAS.
Data Extraction
After retrieving all reports and information from paper and
electronic patient files, the following data were extracted:
sex, age, indication for surgery, type of surgery, ASA grade,
POSSUM score, P-POSSUM score, CR-POSSUM score,
Table 1 Definitions of Separate Complications
Surgical complications
Wound hemorrhage Local hematoma requiring evacuation
Deep hemorrhage Postoperative bleeding requiring re-exploration
Burst abdomen Deep wound breakdown, requiring surgical closure of the abdominal wall
Deep infection The presence of an intra-abdominal collection confirmed clinically or radiologically
Anastomotic leak Discharge of bowel content via the drain, wound, or abnormal orifice
Wound infection Wound cellulitis or the discharge of purulent exudate and the necessity of opening the wound
Medical complications
Chest infection Production of purulent sputum with positive bacteriological cultures, with or without chest radiography
changes or pyrexia or consolidation seen on chest radiograph
Urinary infection The presence of >10
5 bacteria/ml with the presence of white cells in the urine in previously clear urine
Septicemia Positive blood culture
Pyrexia of unknown origin Any temperature above 37°C for more than 24 h occurring after the original pyrexia following surgery (if
present) had settled, for which no obvious cause could be found
Deep venous thrombosis and
pulmonary embolus
When suspected, confirmed radiologically by venography or ventilation/perfusion scanning or diagnosed
at post mortem
Cardiac failure Symptoms or signs of left ventricular or congestive cardiac failure (alteration from preoperative measures)
Impaired renal function Arbitrarily defined as an increase in blood urea of >5 mmol/l from preoperative levels
Hypotension A fall in systolic blood pressure below 90 mmHg for more than 2 h as determined by sphygmomanometry
or arterial pressure transducer measurement
Respiratory failure Respiratory difficulty requiring emergency ventilation
Complications had to occur within 30 days after surgery
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fluid intake, urinary output, stoma production, nasogastric
tube production, length of stay in the hospital, number of
readmissions, complication, and mortality rate.
In the ERAS group, additional data were prospectively
collected: first day of defecation, length of epidural
analgesia, first day of mobilization, and the number of
days that oral analgesia was used.
ERAS (%) (n=61) Control (%) (n=122) P value
Characteristic
Male
a 36.1 (n=22) 50.8 (n=62) 0.06
Female
a 63.9 (n=39) 49.2 (n=60)
Age (years)
b 57 (17.6) 60 (17.4) 0.39
POSSUM
b 7.50 (6.1) 8.37 (6.7) 0.37
P-POSSUM
b 2.59 (2.9) 2.57 (2.8) 0.92
CR-POSSUM
b 2.75 (3.2) 2.79 (3.2) 0.93
Stoma formation
a 11.5 (n=7) 9.0 (n=11) 0.60
Type of surgery
a 0.95
c
Ileocecal resection 21.3 (n=13) 19.7 (n=24)
Right hemicolectomy 37.7 (n=23) 39.3 (n=48)
Left hemicolectomy/resection of sigmoid 3.3 (n=2) 3.3 (n=4)
(Low) anterior resection 24.6 (n=15) 24.6 (n=30)
Subtotal colectomy 13.1 (n=8) 13.1 (n=16)
Type of disease
a 0.83
c
Cancer 75.4 (n=46) 77.1 (n=94)
Inflammatory bowel disease 23.0 (n=14) 21.3 (n=26)
Diverticulitis 1.6 (n=1) 1.6 (n=2)
ASA grade
a 0.1
c
1 29.5 (n=18) 25.4 (n=31)
2 59.0 (n=36) 53.3 (n=65)
3 11.5 (n=7) 21.3 (n=26)
Table 2 Patient Characteristics
and Types of Surgery
aThe first number is the per-
centage, and the number in
between the brackets is the
absolute number
bThe first number is the mean,
and the number in between
brackets is the standard deviation
cThese P values represent the
overall similarity of the two
groups in these characteristics
ERAS%;(n) Standard care%; (n) P value
Surgical complications
a
Wound hemorrhage 0 0
Deep hemorrhage 4.9 (3) 0.8 (1) 0.11
Anastomotic leak 3.3 (2) 7.4 (9) 0.34
Wound infection 4.9 (3) 11.5 (14) 0.18
Deep infection 1.6 (1) 6.6 (8) 0.28
Burst abdomen 1.6 (1) 4.1 (5) 0.67
Medical complications
a
DVT/embolus 0 0
Chest infection 1.6 (1) 4.1 (5) 0.67
Cardiac failure 0 (0) 2.5 (3) 0.55
Urinary infection 0 (0) 6.6 (8) 0.05
Septicemia 0 (0) 3.3 (4) 0.30
Pyrexia of unknown origin 0 (0) 0 (0)
Impaired renal function 0 (0) 2.5 (3) 0.55
Hypotension 0 (0) 0 (0)
Respiratory failure 1.6 (1) 2.5 (3) 0.99
Total number of complications
b 12 63 0.0001
Patients with complication(s) 14.8 (9) 33.6 (41) 0.008
Table 3 Morbidity Rates in the
ERAS and Control Group
aFirst number is percentage, and
the number in brackets is abso-
lute number
bOnly the absolute number is
shown
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The primary outcome measures were mortality and mor-
bidity. Mortality was defined as death within 30 days after
surgery. A complication was defined as an unfavorable
postoperative course with the need for an intervention to
prevent further harm, according to the definition of the
Dutch Association of Surgeons. Individual complications
were defined as stated in Table 1. Secondary outcome
measures were fluid intake, reinsertion of nasogastric tubes,
number of relaparotomies, length of hospital stay, and
number of readmissions within 30 days.
Analysis
The analysis was by intention-to-treat principles. No
patients were excluded for reasons of protocol violations.
Statistical analyses were performed with SPSS® version
16.0(SPSS, Inc., Chicago IL) for Windows® and STATS
direct® (Altrinchem, UK). Medians and ranges or means and
standard deviations are presented for all continuous outcome
measures. Comparisons between the ERAS and conventional
postoperative care group were made using the chi-square test
for binary outcomes, and the Student’s t test was used for
continuous outcomes. Nonparametric tests were carried out
to calculate statistical differences in POSSUM scores.
Results
Sixty-one patients, treated according to the ERAS program,
were matched with 122 historical controls who had
conventional postoperative care.
The two groups were similar with respect to age, ASA grade,
P-Possum (Portsmouth-Possum), CR-Possum (Colorectal-
Possum) score, type of surgery, stoma formation, and type of
disease (Table 2). Women were slightly overrepresented in the
ERAS population (63.9% vs. 36.1%; P=0.06). Fifty-seven
patients (93%) who were treated in the ERAS group had an
epidural catheter until the second postoperative day (median;
range, 1–4). Four patients in whom placing the epidural
catheter could not be realized received a patient-controlled
analgesia pump. Patients were mobilized out of bed on the first
postoperative day (median; range, 0–3). The stools were
passed on day 3 (median; range, 0–11) versus 4 days (median;
range, 1–8) in the control group. Nonsteroidal anti-
inflammatory drugs were used until day 4 (median; range, 0–
15). Paracetamol was used until day 6 (median; range, 0–40).
In the control group, 77 patients had epidural anesthesia (63%).
The morbidity rate was higher in the control group than in
the ERAS group (33.6% vs. 14.8%; P<0.01). Total number
of complications amounted 63 in the control group versus 12
in the ERAS group (P=<0.01). Corrected for gender, the
control group had a 3.4 times higher risk to develop an
unfavorable postoperative course than the ERAS group.
Individual complications were similar in both groups, except
for urinary tract infections. None of the patients in the ERAS
group developed a urinary tract infection versus 6.6% of the
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Figure 3 Total fluid intake (ml/day).
92 J Gastrointest Surg (2010) 14:88–95patients in the control group (P=0.05). Septicemia occurred
in none of the patients in the ERAS group; the incidence was
3.3% in the control group (P=0.30). Of the patients in the
ERAS group, 4.9% developed a wound infection versus
11.5% of the patients in the control group (P=0.18). In the
control group, 6.6% of the patients developed a deep surgical
site infection. For ERAS, this amounted 1.6% (P=0.28).
Anastomotic leakage occurred more often in patients who
had conventional postoperative care (7.4% vs. 3.3%; P=
0.34). A dehiscence of all layers of the abdominal wall was
seen in 1.6% in the ERAS group and in 4.1% of the patients
in the control group (P=0.67; Table 3).
No patient died in the ERAS group within 30 days after
surgery. Two patients in the control group died (1.6%;
P=0.55). One patient developed congestive heart failure
after fluid resuscitation for hypotension. Eight days later,
she became septicemic, a laparotomy was carried out, and
bowel ischemia was found. The other patient also received
an excess of fluid because of her low urine output and low
fluid intake. Nevertheless, her renal function deteriorated.
Four days later, she also developed fatal heart failure.
Patients receiving ERAS postoperative care were ad-
ministered significantly less intravenous fluid during (day
of) surgery and postoperative day 1 till 5 (P<0.001). Oral
intake was higher than in the control group on day of, first,
and second postoperative day (P<0.001). This led to a
larger urinary production on the first three postoperative
days in the control group (P<0.05). Total fluid intake was
higher in the second and third postoperative days (P<0.05;
Figs. 1, 2, 3, and 4).
Reinsertion of nasogastric tubes were similar in both
populations (P=0.85; Table 4). Patients treated according to
the ERAS regime spent significantly fewer days in the
hospital (median 6; range 3–50) than the control group
(median 9; range 3–138 ; P=0.032). The number of
readmissions was similar in both groups (3.3% ERAS vs.
1.6% control; P=0.60; Table 4). Two patients in the ERAS
group were readmitted with surgical site infections. One
developed a presacral abscess which was drained trans-
rectally. The other patient developed a wound abscess
which was incised and drained. One patient in the control
group developed an intra-abdominal abscess which was
treated conservatively. The other patient had successful
conservative treatment for a gastro paresis.
Discussion
The results of this study suggest that the Enhanced Recovery
After Surgery program is superior to conventional postop-
erative care for patients undergoing elective colonic or rectal
resection. Patients treated according to an ERAS program
develop significantly less complications and have shorter
hospital stay.
This study is a historic cohort study with carefully
matched controls. The control group was chosen from years
prior to the introduction of the ERAS program. Because the
discharge criteria were identical in both groups, further
reduction of bias was achieved. Observer bias was avoided,
though awareness about early recovery may have influ-
enced decisions on early discharge. On the other hand, data
in the ERAS group were collected prospectively. The
historic nature of the control group is likely to have caused
the underreporting of complications, thus leading to an
overestimation of the beneficial effect of ERAS. Since
patients in both groups were operated by the same team of
surgeons, selection bias is thought to be small. A
randomized trial on ERAS is difficult to perform because
running traditional and ERAS care simultaneously carry the
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Figure 4 Urinary output (ml/day).
ERAS % (n) P value % (n) Control
Mortality
a 0 (0) 1.6 (2) 0.55
Number of reinserted nasogastric tubes
a 19.7 (12) 21.3 (26) 0.85
Time to first defecation (days)
b 3( 0 –11) 4 (1–8)
Length of hospital stay (days)
b 6( 3 –50) 9 (3–138) 0.021
Number of readmissions
a 3.3 (2) 1.6 (2) 0.60
Number of relaparotomies
a 14.8 (9) 17.2 (21) 0.83
Table 4 Mortality and Second-
ary Outcomes of the Patients in
the ERAS and Control Group
aFirst number is percentage, and
the number in brackets is abso-
lute number
bFirst number is median, and
the number in brackets is range
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nursing and medical staff would be impossible. To
overcome these flaws, the design of such a study is
challenging. In our study, patients were carefully matched.
Women were slightly overrepresented in the ERAS group
(P=0.06). Literature states male gender predisposes to an
increased incidence of anastomotic leakage after colorectal
surgery. One of the main theories is the higher levels of
estrogens in women and anatomical differences of the
pelvis.
19 Further analysis of the data excluded gender as a
risk factor for the development of complications. There
were less ASA 3 in the ERAS population (not significant).
After excluding ASA 3 patients from analysis, significant
differences in total number of complications and number of
patients with one or more adverse events persisted.
In this study, the targets of ERAS were obtained. All
ERAS patients were informed in a standardized way in the
outpatient clinic. They received a daily perioperative
schedule. Patients knew what was expected and allowed.
In the conventional group, it is likely information was not
uniform due to variance in information between the
individual surgeons. Second, all patients of ERAS received
preoperative carbohydrate loading where none of the
conventional treated patients had Pre-Op. Since it was
policy not to apply colonic lavages before the ERAS era,
there was no difference between both groups. Epidural use
was good practice in the conventional group; however, in
the ERAS protocol it was one of the key elements. This led
to a higher epidural use in the ERAS population (93% vs.
63%, respectively; P<0.001). Epidural analgesia, one of the
main issues in fast track protocols, has been suggested to
provide an optimal pain relief, thus reducing surgical stress
response, and may reduce postoperative morbidity and
mortality.
3,20–22 Rodgers et al.
23 found a significant
reduction in deep vein thrombosis (DVT), pulmonary embo-
lism, transfusion requirements, pneumonia, other infections,
and respiratory depression in patients with neuroaxial block-
ade. It is likely that this difference contributes to a reduced
complication rate in ERAS. Patients in the ERAS group
received less fluid intravenously and started drinking sooner
after surgery. Total fluid intake and urinary production was
higher in the control group. In our findings, morbidity was
higher in the control group. Excessive fluid administration is
thought to contribute to an increased complication rate.
24–27 It
is important to realize more elements than mentioned above
may contribute to improved outcome: the use of short-acting
and oral anesthetics and prokinetics, lack of premedication
and nasogastric tubes, early removal of catheters and drains,
minimal length incisions, early mobilization, and the preser-
vation of normothermia.
20
It is likely that the combination of elements in ERAS
favored uncomplicated outcome after colorectal surgery.
Mortality did not differ between both groups. Two patients
(83 and 85 years old) in the control group died because of
cardiac complications. Patients in the control group had an
almost threefold risk to develop one or more complications.
Individual complications failed to reach significance. Since
data collection in the historic group could lead to under-
reporting of minor complications, this is less likely for
major complications, e.g., anastomotic leakage, surgical site
infections, and burst abdomen failed significance. All,
however, tend to be more frequent in the conventional care
group.
Although this ERAS program is evidence-based, some
improvements can be made. Recent evidence suggests that
perioperative supplemental oxygen administration reduces
the incidence of surgical wound infections.
28 It exposes the
patient to little or no risks, has little associated costs, while
it reduces the incidence of wound infections by half.
29 The
addition of specialized nutritional products to the standard
carbohydrate drinks, offered to patients in the used ERAS
program, also shows promising results towards reducing
complications after gastrointestinal surgical procedures.
The specialized nutritional products are the amino acids
arginine and glutamine, omega-3 fatty acids, and nucleo-
tides in the form of RNA. Wound infections, anastomotic
leakage, abdominal abscesses, and pneumonia were signif-
icantly reduced.
30
Patients who were treated according to the ERAS
program spent significantly less time in the hospital. This
did not result in more readmissions which reflects early
recovery, probably due to a more favorable postoperative
course. Besides, this implies benefit for the hospital
resources because with the implementation of the ERAS
program a higher level of cost-effectiveness can be reached.
This study demonstrates that the program as a whole is
clearly beneficial and not flawed with unexpected negative
effects. Epidural analgesia and a restricted fluid adminis-
tration are thought to be the main contributing factors to a
favorable outcome. More research is necessary to optimize
perioperative care.
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